A detailed history of Scientech Research LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 24,022 shares of EXEL stock, worth $880,406. This represents 0.23% of its overall portfolio holdings.

Number of Shares
24,022
Previous 11,771 104.08%
Holding current value
$880,406
Previous $305 Million 161.88%
% of portfolio
0.23%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$25.39 - $36.46 $311,052 - $446,671
12,251 Added 104.08%
24,022 $800 Million
Q3 2024

Nov 14, 2024

BUY
$21.96 - $27.6 $258,491 - $324,879
11,771 New
11,771 $305 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.8B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.